The webinar covered processes for working with aggregated clinical data in the COMBINE consortium and AMR Accelerator. Firstly, the team outlined a set of procedures established for assessing the ethical […]
This workshop provided an open discussion forum to identify, propose and prioritise specific challenges, success and risk factors in the development of vaccines against nosocomial AMR pathogens. Participants included experts […]
Bringing together 60+ senior leaders from large pharma, innovative biotech, academia and investment companies, this conference will discuss data-driven and solution-based approaches that focus on developing high value clinical candidates, […]
As AMR emerges, new strategies for the treatment of infection and identification of resistant microbes are crucial. This JPIAMR activity, led by the UK Medical Research Council (MRC) with support […]
The COMBINE project is part of the IMI AMR Accelerator. One of the scientific aims of COMBINE is to improve and standardize the pneumonia animal model used in AMR research […]
This workshop will explore combination therapy, from treatment to diagnostics. This will be a hands-on workshop with lectures and ample time for discussions. This workshop will be held online and […]
GARDP organises a live webinar that will feature presentations on the following topics: – The AMR Studio: a multidisciplinary podcast on antimicrobial resistance (Eva Garmendia) – Resources by the British […]
More information here.
Download the webinar flyer and agenda in PDF format.
Time: November 6, 15:00 - 16:30 CEST Speakers: Radu Botgros, M.D., Senior Scientific Officer for the Office of Health Threats and Vaccines Strategy at the European Medicines Agency (EMA). AMR Accelerator’s COMBINE and […]